3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
13
Burkitt Lymphoma
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
3
Smoldering Multiple Myeloma
2
Neoplasm Metastasis
2
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Immunoglobulin Light-chain Amyloidosis
2
Down Syndrome
2
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Neoplasms
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Hodgkin Disease
1
Fatigue
1
Brain Neoplasms
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
venetoclax
28
Rituximab
22
ibrutinib
21
acalabrutinib
21
Cyclophosphamide
20
Specimen Handling
18
obinutuzumab
15
Biopsy
14
fludarabine
13
zanubrutinib
10
pirtobrutinib
10
fludarabine phosphate
9
Magnetic Resonance Spectroscopy
8
Bendamustine Hydrochloride
8
idelalisib
6
Whole-Body Irradiation
6
Mycophenolic Acid
6
Lenalidomide
6
CT-P10
6
ARQ531
6
Cyclosporine
5
Sirolimus
4
Peripheral Blood Stem Cell Transplantation
4
pembrolizumab
3
Vincristine
3
Tacrolimus
3
Prednisone
3
Doxorubicin
3
Disulfides
3
Cyclosporins
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Lymphocytic, Chronic, B-Cell
×
auricularum
×
90 days
×
Clear all
No trials found.